Ligand Pharmaceuticals Posts Q3 Adjusted EPS of $2.67
Q3 adjusted EPS was $2.67 per share, versus the FactSet estimate of $2.33.
Story updates
11:08:21 AM UTC
SquawkNews
*-- Earnings Flash (LGND) Ligand Pharmaceuticals Incorporated Reports Q3 Revenue $78.7M, vs. FactSet Est of $77.0M